A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-28
DOI
10.3389/fonc.2021.579488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Antiproliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATP
- (2018) Rakesh K. Singh et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Review of Drug Repositioning Approaches and Resources
- (2018) Hanqing Xue et al. International Journal of Biological Sciences
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
- (2017) J. Javier Hernandez et al. Frontiers in Oncology
- Hydrogen (H2) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
- (2016) Yaxing Zhang et al. Frontiers in Pharmacology
- Mechanisms of isoproterenol-induced cardiac mitochondrial damage: protective actions of melatonin
- (2015) Debasri Mukherjee et al. JOURNAL OF PINEAL RESEARCH
- Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
- (2015) A Eriksson et al. Blood Cancer Journal
- Deficiency in Either 4E-BP1 or 4E-BP2 Augments Innate Antiviral Immune Responses
- (2014) Atef Nehdi et al. PLoS One
- The Clinical Relevance of Cancer Cell Lines
- (2013) J.-P. Gillet et al. JNCI-Journal of the National Cancer Institute
- Technologies for deriving primary tumor cells for use in personalized cancer therapy
- (2013) Abhisek Mitra et al. TRENDS IN BIOTECHNOLOGY
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+Biosynthesis, in Human Cancer Cells
- (2012) Bo Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Contribution of intracellular ATP to cisplatin resistance of tumor cells
- (2012) Verena Schneider et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- The beta2-adrenergic receptor on T and B lymphocytes: Do we understand it yet?
- (2011) Virginia M. Sanders BRAIN BEHAVIOR AND IMMUNITY
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- Chemoprevention: First line of defence
- (2011) Lauren Gravitz NATURE
- Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue
- (2010) Ian A Cree et al. CURRENT OPINION IN PHARMACOLOGY
- Chemosensitivity and chemoresistance testing in ovarian cancer
- (2009) Ian A Cree CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion, AMPK activation and induces senescence
- (2009) Oluwakemi Obajimi et al. PROSTATE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search